[48 Hours Remaining]: Sniper Report

Dear Undefined, I planned on dropping my latest Sniper Report Alert yesterday… A $2 Pharma stock which I believe could soar to $10… Or even $20...thanks to a catalyst no one is really talking about. However, a favorable jobs report on Friday… Sent stocks soaring and I got caught up trading all day. That said, I’m pulling the trigger on Monday… No ifs and or buts about it… If you need a rundown on why it’s such a compelling opportunity here it is: - The CEO has disclosed to the SEC he’s bought shares four times over the last nine days... scooping up a total of 550K shares during that stretch. - State and local governments rely on the company for COVID-19 testings - Already administered over 1 million COVID tests - A working relationship with pharma-giant Pfizer. - One of the few commercial laboratories serving all 50-states - Developed a partnership with NYC to provide COVID-19 testing to all of its 11 hospitals and 70+ acute care facilities I know what you might be thinking… COVID is last month’s news… No one cares anymore… But the reality is… This company is the leader at administering tests… Think about all the buildings and offices across America and how they’ll get their workers back... Testing and social distancing is the only thing that’s shown to work from preventing the virus. This could be… the easiest money I make on a trade. And right now… you’re going to completely miss out on it. Sniper Report doesn’t just give you access to this alert… But it locks you in for 12 months of my highest conviction swing-trade alerts. I’ve said what I’ve had to say about this… Only you can take the next step. Now, I’ve made a small fortune over the years… It didn’t happen because I passed up opportunities like this one… It’s because I took action… [The next move is on you.]( You’ve got till midnight on Sunday to make a move. After that, I’m closing down enrollment. If you haven’t noticed I’ve discounted Sniper by 70% Expect prices to go back up on Monday. [The clock is ticking…]( [Don’t be left behind]( [Be the first to get alerted when the Sniper Report Alert gets dropped.]( Kyle Dennis [Special]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.